Media Coverage

Cell Reprogramming Startup Bit Bio Inks Pact with Charles River

living cells in a petri dish

Xconomy

Charles River Laboratories International is making moves in the cell therapy space after signing on the cell reprogramming startup Bit Bio and announcing plans to acquire a biomaterials company for $380 million. The Wilmington, MA-based contract research organization (CRO) last week announced that it has entered into an exclusive discovery and safety services partnership with Bit Bio.

Read the full article